BioNTech Vaccine Treats MS in Mice Without Dampening Immune System
multiplesclerosisnewstoday.com
multiplesclerosisnewstoday.com
The PIpepTolDC treatment is expensive because it is labor intensive. A technician must take some of the patient's blood, isolate their immune cells, replicate the cells, desensitize them, and then inject them back into the patient. BioNTech's treatment is a simple injection and should be inexpensive.
[0] https://www.precisionvaccinations.com/type-1-diabetes-vaccin...
"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis", https://www.science.org/doi/full/10.1126/science.aay3638 (not Open Access)